Preisverhandlungsliste

Schwacher Bedarf und niedrige Preise: HP-Ergebnisse spiegeln sich wider, 10 Medikamente auf Medicare’s Preisverhandlungsliste und weitere Neuigkeiten, um den Tag zu beginnen.

HP’s results show effects of weaker demand and soft pricing- HP recently released its financial results for the quarter, and the numbers indicate that the company has been facing challenges due to weaker demand and soft pricing. This has affected the company’s overall revenue and profitability. The decline in demand…